Skip to main navigation Skip to search Skip to main content

The use of gelclari in the treatment of pain from chemotherapy induced stomatitis in patients with hematologic malignancies.

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/04 → 6/30/06

Funding

  • OSI Pharmaceuticals: $7,502.00